Guidance

Cannabis-based medicines: expert panel

An expert panel of clinicians has been set up to assess applications for special licences to prescribe cannabis-based medicines.

Documents

Details

The government has announced a review of cannabis-based medicines. During the period of the review, the government will consider licence applications for the use of cannabis-based medicines in exceptional cases where there is an unmet clinical need. This expert panel, made up of clinicians, will advise ministers on any licence applications to prescribe cannabis-based medicines.

Published 27 June 2018
Last updated 27 September 2018 + show all updates
  1. Updated dates for when the expert panel will meet to review received licenced applications.
  2. Email for the Expert Panel updated.
  3. Added a paragraph under - Process for considering a license.
  4. Added a link to guidance on the expert panel's ways of working.
  5. Added a link to panel members biographies and disclosures of interest.
  6. First published.